Day: February 1, 2021

WESTLAKE VILLAGE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced the commencement of an underwritten public offering of $150.0 million of shares of its common stock. All of the shares in the offering are being sold by Arcutis. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering. In addition, Arcutis intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in...

NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock, of Superconductor Technologies Inc. Superconductor Technologies Inc.’s common stock was suspended on September 30, 2020 and has not traded on Nasdaq since that time.Nasdaq also announced today that it will delist the common stock of Gulfport Energy Corporation. Gulfport Energy Corporation’s common stock was suspended on November 27, 2020 and has not traded on Nasdaq since that time.Nasdaq also announced today that it will delist the common stock of Apex Global Brands Inc. Apex Global Brands Inc.’s common stock was suspended on November 5, 2020 and has not traded on Nasdaq since that time.Nasdaq also announced today that it will delist the common stock of Pareteum Corporation. Pareteum Corporation’s common stock...

TAMPA, FL, Feb. 01, 2021 (GLOBE NEWSWIRE) — Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that it will postpone its virtual roadshow, previously scheduled for Wednesday, February 3, 2021 at 11:00 a.m. Eastern Time, to a later date that will be announced via press release.“The virtual roadshow will be postponed to a later date, which will be announced via press release accompanied by a webcast link and dial-in numbers once finalized,” said Suren Ajjarapu, Chief Executive Officer of Trxade Group. “I would like to thank our shareholders for their patience as we continue to execute upon our near-term business objectives. I look forward to presenting an overview of the business model, short-term growth initiatives and a corporate update to both new and prospective investors.”About Trxade...

MONTREAL, Feb. 01, 2021 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (“Premier Health” or the “Corporation”), a leading Canadian Healthtech company, announces today that it has entered into an agreement with Acumen Capital Finance Partners Limited (the “Underwriter”) to purchase on a bought deal basis 3,810,000 common shares of Premier Health (“Common Shares”) at a price of $1.05 per Common Share (the “Offering Price”) for gross proceeds to the Corporation of approximately $4.0 million (the “Offering”).The Corporation has granted the Underwriter an over-allotment option exercisable at any time up to 30 days following the closing of the Offering (the “Closing Date”), to purchase up to an additional 571,500 Common Shares at a price per Common Share equal to the Offering Price, to cover over-allotments, if any, and...

UTRECHT (Pays-Bas) et CAMBRIDGE, Massachusetts (États-Unis), 01 févr. 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS), une société d’oncologie au stade clinique qui développe des anticorps multispécifiques de pleine longueur innovants (Biclonics® et Triclonics™), a annoncé aujourd’hui la participation de Bill Lundberg, Président-directeur général, aux conférences des investisseurs suivantes :Guggenheim Healthcare Talking 2021/Oncology Days (discussion informelle) : le vendredi 12 février de 10 h 30 à 10 h 55 HNE.LifeSci Partners Precision Oncology Day (présentation) : le mercredi 17 février de 10 h 30 à 10 h 55 HNE.2021 SVB Leerink Global Healthcare Conference (présentation) : le vendredi 26 février de 8 h 40 à 9 h 10 HNE.Les diffusions en direct des présentations seront disponibles sur la page consacrée aux investisseurs...